Utility of Transbronchial vs Surgical Lung Biopsy in the Diagnosis of Suspected Fibrotic Interstitial Lung Disease

Chest

Volumn 151, Issue 2, 2017, Pages 389-399

  Sheth, Jamie S ^a   Belperio, John A ^b   Fishbein, Michael C ^c   Kazerooni, Ella A ^a   Lagstein, Amir ^a   Murray, Susan ^a   Myers, Jeff L ^a   Simon, Richard H ^a   Sisson, Thomas H ^a   Sundaram, Baskaran ^d   White, Eric S ^a   Xia, Meng ^a   Zisman, David ^e   Flaherty, Kevin R ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d THOMAS JEFFERSON UNIVERSITY   (United States)

^e Sansum Clinic   (United States)

Author keywords

idiopathic interstitial pneumonia; idiopathic pulmonary fibrosis; interstitial lung disease; lung biopsy

Indexed keywords

ADULT; CLINICAL ARTICLE; CONFERENCE PAPER; FEMALE; FIBROSING ALVEOLITIS; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; INTERSTITIAL LUNG DISEASE; INTERSTITIAL PNEUMONIA; LUNG BIOPSY; MALE; SURGICAL LUNG BIOPSY; TRANSBRONCHIAL BIOPSY; AGED; ALLERGIC PNEUMONITIS; BIOPSY; BRONCHIOLITIS; BRONCHIOLITIS OBLITERANS ORGANIZING PNEUMONIA; BRONCHOSCOPY; COHORT ANALYSIS; DIAGNOSTIC IMAGING; FORCED EXPIRATORY VOLUME; LUNG; LUNG DIFFUSION CAPACITY; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; PROCEDURES; RETROSPECTIVE STUDY; SURGERY; VITAL CAPACITY; X-RAY COMPUTED TOMOGRAPHY;

ADULT; AGED; ALVEOLITIS, EXTRINSIC ALLERGIC; BIOPSY; BRONCHIOLITIS; BRONCHOSCOPY; COHORT STUDIES; CRYPTOGENIC ORGANIZING PNEUMONIA; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; LUNG; LUNG DISEASES, INTERSTITIAL; MALE; MIDDLE AGED; PULMONARY DIFFUSING CAPACITY; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED; VITAL CAPACITY;

EID: 85011534543     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1016/j.chest.2016.09.028     Document Type: Conference Paper

References (43)

1. 1 Flaherty, K.R., Toews, G.B., Travis, W.D., et al. Clinical significance of histological classification of idiopathic interstitial pneumonia. Eur Respir J 19:2 (2002), 275–283.
2. 2 Flaherty, K.R., Travis, W.D., Colby, T.V., et al. Histopathologic variability in usual and nonspecific interstitial pneumonias. Am J Respir Crit Care Med 164:9 (2001), 1722–1727.
3. 3 Katzenstein, A.L., Fiorelli, R.F., Nonspecific interstitial pneumonia/fibrosis. Histologic features and clinical significance. Am J Surg Pathol 18:2 (1994), 136–147.
4. 4 Nagai, S., Kitaichi, M., Itoh, H., Nishimura, K., Izumi, T., Colby, T.V., Idiopathic nonspecific interstitial pneumonia/fibrosis: comparison with idiopathic pulmonary fibrosis and BOOP. Eur Respir J 12:5 (1998), 1010–1019.
5. 5 Nicholson, A.G., Colby, T.V., du Bois, R.M., Hansell, D.M., Wells, A.U., The prognostic significance of the histologic pattern of interstitial pneumonia in patients presenting with the clinical entity of cryptogenic fibrosing alveolitis. Am J Respir Crit Care Med 162:6 (2000), 2213–2217.
6. 6 Travis, W.D., Matsui, K., Moss, J., Ferrans, V.J., Idiopathic nonspecific interstitial pneumonia: prognostic significance of cellular and fibrosing patterns: survival comparison with usual interstitial pneumonia and desquamative interstitial pneumonia. Am J Surg Pathol 24:1 (2000), 19–33.
7. 7 Bjoraker, J.A., Ryu, J.H., Edwin, M.K., et al. Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 157:1 (1998), 199–203.
8. 8 Lama, V.N., Flaherty, K.R., Toews, G.B., et al. Prognostic value of desaturation during a 6-minute walk test in idiopathic interstitial pneumonia. Am J Respir Crit Care Med 168:9 (2003), 1084–1090.
9. 9 Raghu, G., Collard, H.R., Egan, J.J., et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 183:6 (2011), 788–824.
10. 10 Raghu, G., Rochwerg, B., Zhang, Y., et al. An official ATS/ERS/JRS/ALAT clinical practice guideline: treatment of s. An update of the 2011 clinical practice guideline. Am J Respir Crit Care Med 192:2 (2015), e3–e19.
11. 11 Travis, W.D., Costabel, U., Hansell, D.M., et al. An official American Thoracic Society/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 188:6 (2013), 733–748.
12. 12 American Thoracic Society, European Respiratory Society. American Thoracic Society/European Respiratory Society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am J Respir Crit Care Med 165:2 (2002), 277–304.
13. 13 Katzenstein, A.L., Myers, J.L., Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification. Am J Respir Crit Care Med 157:4 Pt 1 (1998), 1301–1315.
14. 14 Idiopathic Pulmonary Fibrosis Clinical Research Network, Raghu, G., Anstrom, K.J., King, T.E. Jr., et al. Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis. N Engl J Med 366:21 (2012), 1968–1977.
15. 15 Idiopathic Pulmonary Fibrosis Clinical Research Network, Martinez, F.J., de Andrade, J.A., Anstrom, K.J., et al. Randomized trial of acetylcysteine in idiopathic pulmonary fibrosis. N Engl J Med 370:22 (2014), 2093–2101.
16. 16 Noble, P.W., Albera, C., Bradford, W.Z., et al. Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials. Lancet 377:9779 (2011), 1760–1769.
17. 17 King, T.E. Jr., Bradford, W.Z., Castro-Bernardini, S., et al. A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis. N Engl J Med 370:22 (2014), 2083–2092.
18. 18 Richeldi, L., du Bois, R.M., Raghu, G., et al. Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. N Engl J Med 370:22 (2014), 2071–2082.
19. 19 Richeldi, L., Costabel, U., Selman, M., et al. Efficacy of a tyrosine kinase inhibitor in idiopathic pulmonary fibrosis. N Engl J Med 365:12 (2011), 1079–1087.
20. 20 Flaherty, K.R., King, T.E. Jr., Raghu, G., et al. Idiopathic interstitial pneumonia: what is the effect of a multidisciplinary approach to diagnosis?. Am J Respir Crit Care Med 170:8 (2004), 904–910.
21. 21 Hunninghake, G.W., Zimmerman, M.B., Schwartz, D.A., et al. Utility of a lung biopsy for the diagnosis of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 164:2 (2001), 193–196.
22. 22 Raghu, G., Mageto, Y.N., Lockhart, D., Schmidt, R.A., Wood, D.E., Godwin, J.D., The accuracy of the clinical diagnosis of new-onset idiopathic pulmonary fibrosis and other interstitial lung disease: a prospective study. Chest 116:5 (1999), 1168–1174.
23. 23 Flaherty, K.R., Thwaite, E.L., Kazerooni, E.A., et al. Radiological versus histological diagnosis in UIP and NSIP: survival implications. Thorax 58:2 (2003), 143–148.
24. 24 Quadrelli, S., Molinari, L., Ciallella, L., Spina, J.C., Sobrino, E., Chertcoff, J., Radiological versus histopathological diagnosis of usual interstitial pneumonia in the clinical practice: does it have any survival difference?. Respiration 79:1 (2010), 32–37.
25. 25 Behr, J., Kreuter, M., Hoeper, M.M., et al. Management of patients with idiopathic pulmonary fibrosis in clinical practice: the INSIGHTS-IPF registry. Eur Respir J 46:1 (2015), 186–196.
26. 26 Tiitto, L., Heiskanen, U., Bloigu, R., Paakko, P., Kinnula, V., Kaarteenaho-Wiik, R., Thoracoscopic lung biopsy is a safe procedure in diagnosing usual interstitial pneumonia. Chest 128:4 (2005), 2375–2380.
27. 27 Utz, J.P., Ryu, J.H., Douglas, W.W., et al. High short-term mortality following lung biopsy for usual interstitial pneumonia. Eur Respir J 17:2 (2001), 175–179.
28. 28 Lettieri, C.J., Veerappan, G.R., Helman, D.L., Mulligan, C.R., Shorr, A.F., Outcomes and safety of surgical lung biopsy for interstitial lung disease. Chest 127:5 (2005), 1600–1605.
29. 29 Kreider, M.E., Hansen-Flaschen, J., Ahmad, N.N., et al. Complications of video-assisted thoracoscopic lung biopsy in patients with interstitial lung disease. Ann Thorac Surg 83:3 (2007), 1140–1144.
30. 30 Hutchinson, J.P., Fogarty, A.W., McKeever, T.M., Hubbard, R.B., In-hospital mortality after surgical lung biopsy for interstitial lung disease in the United States. 2000 to 2011. Am J Respir Crit Care Med 193:10 (2016), 1161–1167.
31. 31 Casoni, G.L., Tomassetti, S., Cavazza, A., et al. Transbronchial lung cryobiopsy in the diagnosis of fibrotic interstitial lung diseases. PLoS One, 9(2), 2014, e86716.
32. 32 Poletti, V., Hetzel, J., Transbronchial cryobiopsy in diffuse parenchymal lung disease: need for procedural standardization. Respiration 90:4 (2015), 275–278.
33. 33 Gasparini, S., Bonifazi, M., Cryobiopsy for interstitial lung diseases. J Bronchology Interv Pulmonol 23:1 (2016), 4–6.
34. 34 Tomassetti, S., Wells, A.U., Costabel, U., et al. Bronchoscopic lung cryobiopsy increases diagnostic confidence in the multidisciplinary diagnosis of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 193:7 (2016), 745–752.
35. 35 Ravaglia, C., Bonifazi, M., Wells, A.U., et al. Safety and diagnostic yield of transbronchial lung cryobiopsy in diffuse parenchymal lung diseases: a comparative study versus video-assisted thoracoscopic lung biopsy and a systematic review of the literature. Respiration 91:3 (2016), 215–227.
36. 36 Berbescu, E.A., Katzenstein, A.L., Snow, J.L., Zisman, D.A., Transbronchial biopsy in usual interstitial pneumonia. Chest 129:5 (2006), 1126–1131.
37. 37 Tomassetti, S., Cavazza, A., Colby, T.V., et al. Transbronchial biopsy is useful in predicting UIP pattern. Respir Res, 13(1), 2012, 96.
38. 38 Votava J, Belperio JA, Kazerooni EA, et al. Utility of transbronchial biopsy versus surgical lung biopsy in the diagnosis of patients with suspected idiopathic interstitial pneumonia. A22 Interstitial Lung Disease: Evaluation and Pathobiology. Respir Crit Care Med. Abstract issue. 2013; A1089-A1089.
39. 39 Fell, C.D., Martinez, F.J., Liu, L.X., et al. Clinical predictors of a diagnosis of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 181:8 (2010), 832–837.
40. 40 Fraire, A.E., Cooper, S.P., Greenberg, S.D., Rowland, L.P., Langston, C., Transbronchial lung biopsy. Histopathologic and morphometric assessment of diagnostic utility. Chest 102:3 (1992), 748–752.
41. 41 Kendall, D.M., Gal, A.A., Interpretation of tissue artifacts in transbronchial lung biopsy specimens. Ann Diagn Pathol 7:1 (2003), 20–24.
42. 42 Pajares, V., Puzo, C., Castillo, D., et al. Diagnostic yield of transbronchial cryobiopsy in interstitial lung disease:a randomized trial. Respirology 19:6 (2014), 900–906.
43. 43 Leslie, K.O., Gruden, J.F., Parish, J.M., Scholand, M.B., Transbronchial biopsy interpretation in the patient with diffuse parenchymal lung disease. Arch Pathol Lab Med 131:3 (2007), 407–423.